Clinical Trials Directory

Trials / Unknown

UnknownNCT04406844

Issues and Challenges in Cancer Patients on Active Treatment During the COVID-19 Pandemic

An Observational Study to Identify the Issues and Challenges in Cancer Patients on Active Treatment During the COVID-19 Pandemic and the Resulting Lockdown

Status
Unknown
Phase
Study type
Observational
Enrollment
150 (estimated)
Sponsor
Max Healthcare Insititute Limited · Academic / Other
Sex
All
Age
12 Years – 98 Years
Healthy volunteers
Not accepted

Summary

In view of increasing cases of SARS-CoV-2 leading to the COVID-19 Pandemic in India,there has been unprecedented restrictions on travel, work and other aspects of daily life. Our study has been designed to collect data of cancer patients to analyze their issues and challenges during Covid-19 Pandemic.

Detailed description

Protocol No: Onco\_Covid-19 Version no:1.0 Objectives: Firstly the patients recently diagnosed with cancer will be selected for enrollment who are on active treatment during lockdown based on the date of their registration in the hospital. This is followed by a telephonic interview with patients or their attendant to carry out a prospective, cross-sectional, observational study in order to address the issues and challenges faced by them during Lockdown. Collection of data will be done through telephonic communication. Participation in this study will be entirely voluntary. Telephonic verbal consent will be taken from the patients or their attendants before collection of their response on the study questionnaire and then will be asked questions accordingly based on the questionnaire which is available in English and Hindi both. Data and general information regarding participants will only be collected in questionnaire. No personal data of the participants will be taken which will also be conveyed to the participant or attendant during telephonic verbal consent.

Conditions

Timeline

Start date
2020-05-09
Primary completion
2021-06-30
Completion
2021-06-30
First posted
2020-05-28
Last updated
2020-07-22

Locations

1 site across 1 country: India

Source: ClinicalTrials.gov record NCT04406844. Inclusion in this directory is not an endorsement.